Metastatic hormone-sensitive prostate cancer: How should it be treated?

The number of treatment options for metastatic hormone-sensitive prostate cancer has increased substantially in recent years. The classic treatment approach for these patients—androgen-deprivation therapy alone—is now considered suboptimal. Several randomized phase III clinical trials have demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Campos, Fernando, González-San Segundo, Carmen, Conde-Moreno, Antonio José, Couñago, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918528/
https://www.ncbi.nlm.nih.gov/pubmed/33680871
http://dx.doi.org/10.5306/wjco.v12.i2.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918528/
https://www.ncbi.nlm.nih.gov/pubmed/33680871
http://dx.doi.org/10.5306/wjco.v12.i2.43

Ejemplares similares